Topical Voltaren in Otitis Externa

Sieff Medical Center

Status and phase: Terminated; Phase 2

Conditions: Otitis Externa

Treatments: Drug: diclofenac sodium; Drug: dexotc

Study type: Interventional

Funder types: Other

Identifiers

NCT00523120

HP 7-264S

Details and patient eligibility

About

Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.

Full description

anticipated advantages are: reduction of inflammation and edema, no fungal overpopulation- when steroids are employed, contains boric acid as an ingredient, high safety profile, can be switched to antibiotic therapy later, can be used in conjunction wit steroids

Enrollment: 20 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adults having otitis externa as single diagnosis mild to moderate

Exclusion criteria

• Diabetes
• Children
• Pregnant women
• Immune compromise
• Starting other treatment
• Moderate to severe otitis externa

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

20 participants in 2 patient groups

1

Active Comparator group

Description:

voltaren ophta

Treatment:

Drug: diclofenac sodium

2

Active Comparator group

Description:

dexotic

Treatment:

Drug: dexotc